180 Life Sciences (ATNF) Just Raised $425 Million—And It’s Not Just a Biotech Anymore
180 Life Sciences Corp. (NASDAQ:ATNF) is an emerging and unconventional player in the public markets, combining the high-stakes…
Editas Medicine (EDIT)’s $178 Million War Chest: The CRISPR Comeback Investors Can’t Ignore
Editas Medicine Inc. (NASDAQ:EDIT) is a pioneering gene editing company dedicated to translating the revolutionary potential of CRISPR/Cas12a…
Generation Bio (GBIO)’s $100MCash Lifeline: Is a Massive Comeback on the Horizon?
Generation Bio Co. (NASDAQ:GBIO) is a pioneering biotechnology company dedicated to transforming the treatment of genetic diseases through…
Titan Pharma (TTNP): This Tiny Drugmaker Is Taking on Big Pharma — And Could Win!
Titan Pharmaceuticals Inc. (NASDAQ:TTNP) is a specialty pharmaceutical company dedicated to developing innovative therapeutics that address chronic medical…
Health In Tech (HIT) is Making Healthcare Affordable and Scalable for Businesses
Health In Tech Inc. (NASDAQ:HIT) is an innovative Insurtech platform that is reshaping the healthcare benefits landscape for…
Here’s Why Wall Street Is Suddenly Obsessed with ImmunityBio (IBRX)
ImmunityBio, Inc. (NASDAQ:IBRX) is a vertically integrated, commercial-stage biotechnology company dedicated to developing next-generation therapies that harness and…
BioXcel (BTAI)’s BXCL501 Could Be the Game Changer in Treating Agitation Disorders
BioXcel Therapeutics Inc. (NASDAQ:BTAI) is an innovative biopharmaceutical company leveraging cutting-edge artificial intelligence (AI) to discover and develop…
The Future of Gene Therapy is Here with Solid Biosciences (SLDB): A Look at SGT-003
Solid Biosciences Inc. (NASDAQ:SLDB) is a pioneering biotechnology company at the forefront of developing innovative gene therapies aimed…
Can Sol-Gel Technologies (SLGL) Become the Next Big Name in Dermatology?
Sol-Gel Technologies Ltd. (NASDAQ:SLGL) is a clinical-stage biotechnology company focused on the development of innovative dermatological treatments aimed…
Assembly Bio (ASMB): The Future of Chronic Viral Disease Treatment is Here!
Assembly Biosciences, Inc. (NASDAQ:ASMB) is a leading biotechnology company dedicated to developing innovative therapies for the treatment of…
Here’s Why Verastem (VSTM) Is the Next Big Thing in Oncology
Verastem Inc. (NASDAQ:VSTM) is a clinical-stage biopharmaceutical company focused on developing and commercializing targeted therapies for cancers driven…
Kura Oncology (KURA)’s Targeted Therapies Could Dominate the Market
Kura Oncology Inc. (NASDAQ:KURA) is a clinical-stage biopharmaceutical company dedicated to the development of precision medicines for the…
AVITA Medical (RCEL) is Delivering Big Returns for Early Investors—Here’s Why You Should Buy This Now!
AVITA Medical Inc. (NASDAQ:RCEL) is a leading therapeutic company focused on acute wound care, delivering transformative solutions designed…
Here’s Why Eli Lilly (LLY) is the Pharma Stock Everyone is Talking About Right Now
Eli Lilly and Company (NYSE:LLY), founded in 1876, is a global leader in the pharmaceutical industry, renowned for…
Tonix Pharma (TNXP) Jumps 14% – Here’s What You Need to Know
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) has been generating significant market attention due to its promising pipeline and recent…
Wall Street’s Best-Kept Biotech Secret: Crinetics (CRNX) Could Be the Next 10X Stock!
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) is a clinical-stage biopharmaceutical company dedicated to pioneering the development of oral, small-molecule therapeutics…
Forget Glasses—Lenz Therapeutics (LENZ) Just Got FDA Approval for a Daily Eye Drop Fix
Lenz Therapeutics Inc. (NASDAQ:LENZ) is a late-stage clinical and now commercial-stage biopharmaceutical company dedicated to revolutionizing the treatment…
$2.3 Billion Potential? Why Kymera Therapeutics (KYMR) Might Be the Biggest Sleeper Stock in Biotech
Kymera Therapeutics (NASDAQ:KYMR) is a clinical-stage biopharmaceutical company at the forefront of one of the most exciting breakthroughs…